Christopher Patusky, Director at UNITED THERAPEUTICS Corp (UTHR), sold 2,600 shares at $190.52 ($499K) on 2021-05-10, disclosed to the SEC on 2021-05-10.
Scheduled sale ($499k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $192.07 | 2,500 | $480K | 96.2% |
| 2 | $190.52 | 100 | $19K | 3.8% |
| Total | $192.01 avg | 2,600 | $499K | 100% |
| Filing → |
| UTHR | SELL | 2025-12-16 | $496K | — | Filing → |
| UTHR | SELL | 2025-03-20 | $3.0M | — | Filing → |
| UTHR | SELL | 2025-01-13 | $3.3M | — | Filing → |